Beximco Pharmaceuticals court hearings delayed until after April 18
Delay caused by scheduled vacation of Bangladesh's High Court
Company listed on AIM with ticker symbol BXP
Nature of writ petitions remains unspecified
π Full Retelling
Beximco Pharmaceuticals PLC (AIM:BXP) announced in Dhaka that hearings for two writ petitions will commence after April 18, 2025, following a scheduled vacation of the High Court Division of the Supreme Court of Bangladesh. The pharmaceutical company, listed on London's Alternative Investment Market, revealed this development regarding legal proceedings that have been pending in the country's highest judicial body. The delay comes as the court enters its regular vacation period, which has necessitated the rescheduling of these important hearings that were expected to take place earlier in the month. Beximco did not specify the exact nature of the writ petitions or provide details about the potential impact of this postponement on their ongoing operations or business strategy. The company continues to operate in Bangladesh's competitive pharmaceutical sector while navigating these legal challenges that have now been extended beyond the April deadline.
In law, a hearing is the formal examination of a case (civil or criminal) before a judge. It is a proceeding before a court or other decision-making body or officer, such as a government agency or a legislative committee.
Beximco Pharmaceuticals Ltd, also known as Beximco Pharma (stylised as BEXIMCO PHARMA) is a Bangladeshi multinational pharmaceutical company. It is a part of Bangladesh Export Import Company Limited (BEXIMCO).
DHAKA - Beximco Pharmaceuticals PLC (AIM:BXP) announced that hearings for two writ petitions will commence after April 18, following a scheduled vacation of the High Court Division of the Supreme Court of Bangladesh.